CompletedNCT03188601

α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rambam Health Care Campus
Principal Investigator
Eli Lewis, Professor
Ben-Gurion University of the Negev
Enrollment
27 enrolled
Eligibility
18 years · All sexes
Timeline
2018 – 2022

Study locations (4)

Collaborators

Soroka University Medical Center · Tel-Aviv Sourasky Medical Center · Hadassah Medical Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03188601 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency →

← Back to all trials